Anti-Inflammatory Actions of Pycnogenol: Diabetes and Arthritis

Bioactive Food as Dietary Interventions for Diabetes

Volumn , Issue , 2013, Pages 495-501

  Cordova, F M ^a   Marks, M B F ^b   Watson, R R ^a,c,d,e  

^a UNIVERSITY OF ARIZONA   (United States)

^b International Center for Vasectomy Reversal   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

^e Southwest Scientific Editing and Consulting   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84881277234     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-397153-1.00077-9     Document Type: Chapter

References (25)

1. Belcaro G., Cesarone M.R., Errichi B.M., et al. Diabetic ulcers: microcirculatory improvement and faster healing with pycnogenol. Clinical and Applied Thrombosis/Hemostasis 2006, 12:318-323.
2. Belcaro G., Cesarone M.R., Errichi B.M., et al. Treatment of osteoarthritis with Pycnogenol®. The SVOS (san valentino osteo-arthritis study). Evaluation of signs, symptoms, physical performance and vascular aspects. Phytotherapy Research 2008, 22:518-523.
3. Belcaro G., Cesarone M.R., Errichi S., et al. Variations in C-reactive protein, plasma free radicals and fibrinogen values in patients with osteoarthritis treated with pycnogenol. Redox Report 2008, 13(6):271-276.
4. Bentley G., Schonlau F., Zibadi S., Watson R.R. Cost of pycnogenol supplementation and traditional diabetes treatments per unit of improved health outcome. Nutrients, Dietary Supplements and Nutriceuticals 2010, 457-465. Humana Press, New York. R.R. Watson, J. Gerrald, V.R. Preedy (Eds.).
5. Berryman A.M., Maritim A.C., Sanders R.A., Watkins J.B. Influence of treatment of diabetic rats with combinations of pycnogenol, B-carotene, and a-lipoic acid on parameters of oxidative stress. Journal of Biochemical Toxicology 2004, 18(6):345-352.
6. Centers for Disease Control and Prevention National and state medical expenditures and lost earnings attributable to arthritis and other rheumatic conditions - United States, 2003. Morbidity and Mortality Weekly Report 2007, 56:4-7.
7. Centers for Disease Control and Prevention Prevalence of Doctor-diagnosed arthritis and arthritis-attributable activity limitation - United States 2007-2009. Morbidity and Mortality Weekly Report 2010, 59(39):1261-1265.
8. Centers for Disease Control and Prevention National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011 2011, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA.
9. Cesarone M.R., Belcaro G., Rohdewald P., et al. Improvement of diabetic microangiopathy with pycnogenol: a prospective, controlled study. Angiology 2006, 57(4):431-436.
10. Cisar P., Jany R., Waczulikova I., et al. Effects of pine bark extract (Pycnogenol®) on symptoms of knee osteoarthritis. Phytotherapy Research 2008, 22:1087-1092.
11. D'Andrea G. Pycnogenol: a blend of procyanidins with multifaceted therapeutic applications?. Fitoterapia 2010, 81:724-736.
12. Dandona P., Aljada A., Chaudhuri A., Mohanty P., Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005, 111:1448-1454.
13. Farid R., Mirfeizi Z., Mirheidari M., et al. Pycnogenol supplementation reduces pain and stiffness and improves physical function in adults with knee osteoarthritis. Nutrition Research 2007, 27:692-697.
14. Grimm T., Chovanova Z., Muchova J., et al. Inhibition of NF-kB activation and MMP-9 secretion by plasma of human volunteers after ingestion of maritime pine bark extract (pycnogenol). Journal of Inflammation 2006, 3:1-6.
15. Gulati O.P. The nutriceutical pycnogenol: its role in cardiovascular health and blood glucose control. Biomedical Reviews 2005, 16:49-57.
16. Liu X., Wei J., Tan F., et al. Antidiabetic effect of pycnogenol French maritime pine bark extract in patients with diabetes type II. Life Sciences 2004, 75:2505-2513.
17. Liu X., Zhou H., Rohdewald P. French maritime pine bark extract pycnogenol dose-dependently lowers glucose in type 2 diabetic patients. Diabetes Care 2004, 27(3):839.
18. Maimoona A., Naeem I., Saddiqe Z., Jameel K. A review on biological, nutriceutical and clinical aspects of french maritime bark extract. Journal of Ethnopharmacology 2011, 133:261-277.
19. Parveen K., Khan M.R., Mujeeb M., Siddiqui W.A. Protective effects of pycnogenol on hyperglycemia-induced oxidative damage in the liver of type 2 diabetic rats. Chemico-Biological Interactions 2010, 186:219-227.
20. Schafer A., Chovanova Z., Muchova J., et al. Inhibition of COX-1 and COX-2 activity by plasma of human volunteers after ingestion of French maritime pine bark extract (pycnogenol). Biomedicine and Pharmacology 2005, 60:5-9.
21. Spadea L., Balestrazzi E. Treatment of vascular retinopathies with pycnogenol. Phytotherapy Research 2001, 15:219-223.
22. Steigerwalt R., Belcaro G., Cesarone M.R., et al. Pycnogenol improves microcirculation, retinal edema, and visual acuity in early diabetic retinopathy. Journal of Ocular Pharmacology and Therapeutics 2009, 25(6):537-540.
23. Uresin Y., Taylor A.A., Charles K., et al. Efficacy and safety of the direct rennin inhibitor aliskerin and ramipril alone or in combination in patients with diabetes and hypertension. Journal of Renal-Angiotensin - Aldosterone System 2007, 8(4):194-198.
24. Zibadi S., Larson D.F., Watson R.R. Flavonoid-rich dietary supplements' influence on heart failure. Wild-Type Food in Health Promotion and Disease Prevention 2008, 435-442. Humana Press, Totowa, NJ. F. Demeester, R.R. Watson (Eds.).
25. Zibadi S., Rohdewald P.J., Park D., Watson R.R. Reduction of cardiovascular risk factors in subjects with type 2 diabetes by pycnogenol supplementation. Nutrition Research 2008, 28:315-320.